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Infection of microglia and other cells of the macrophage/monocyte lineage in the central nervous system
(CNS) by human immunodeficiency virus type I (HIV-1) underlies the development of giant cell encephalitis
(GCE). It is currently unknown whether GCE depends on the emergence of virus populations specifically
adapted to replicate in cells of the monocyte/macrophage lineage and whether this also leads to the specific
targeting of macrophages in other nonlymphoid tissues. Autopsy samples from lymph node, brain (frontal
region), lung, and full-thickness colon sections were obtained from nine study subjects with GCE and from nine
without. The two groups showed no significant differences in CD4 counts, disease progression, or treatment
history before death. Genetic relatedness between variants recovered from lymph node and nonlymphoid
tissues was assessed by sequence comparison of V3 and p17gag regions using a newly developed method that
scores the sample composition at successive nodes in a neighbor-joining tree. The association index enabled
objective, numerical comparisons on the degree of tissue compartmentalization to be made. High proviral loads
and p24 antigen expression in the brain were confined to the nine individuals with GCE. GCE was also
associated with significantly higher proviral loads in colon samples (median of the GCE group: 1,010
copies/106 cells; median of GCE group, 10/106 cells; P  0.006). In contrast, there were no significant
differences in proviral load between the GCE and GCE groups in lymph node or lung samples, where HIV
infection was manifested predominantly by infiltrates of lymphoid cells. V3 sequences from brain samples of
individuals with GCE showed the greatest compartmentalization from those of lymph node, although samples
from other tissues, particularly the colon, frequently contained variants phylogenetically related to those found
in brain. The existence of shared, distinct populations of HIV specifically distributed in cells of the monocyte/
macrophage lineage was further indicated by immunocytochemical detection of CD68, multinucleated giant
cells expressing p24 antigen in samples of lung and colon in two individuals with GCE. This study provides the
basis for future investigation of possible phenotypic similarities that underline the shared distributions of HIV
variants infecting microglia and tissue macrophages outside the CNS.
The cellular tropism of human immunodeficiency virus type
1 (HIV-1) is governed at a variety of entry and postentry steps,
including the attachment, fusion, and entry of HIV into the
cell, reverse transcription, integration, and gene expression
(16, 31, 39). Differences between CD4 lymphocytes, the prin-
cipal targets of HIV-1 in vivo, and other potential cellular
targets for HIV-1, such as macrophages and microglia in the
brain, exist at many of these levels, particularly in the expres-
sion of CD4 and chemokine coreceptors required for virus
entry. The ability of HIV-1 to target and productively infect
these different cell types in vivo may therefore depend on
strain-specific differences of HIV-1 or on the evolution of
adaptive differences during the course of infection.
Primary and laboratory isolates show a wide range of cellular
tropisms (including ability to grow in transformed T-cell lines,
primary cultures of monocyte-derived macrophages), cytopa-
thology (syncytium induction) and coreceptor usage (CXCR4,
CCR5, CCR3). These differences have in the past been linked
to variability in the rate of disease progression in HIV-infected
individuals, in whom the emergence of CXCR4-using, non-
macrophage tropic isolates of HIV-1 is accompanied by a more
rapid decline in CD4 lymphocyte numbers and the onset of
AIDS-related disease (3, 5, 10, 15, 20, 26, 29, 30, 47, 70, 78).
Much less is understood about the existence of differential
cellular tropism of HIV variants infecting different anatomical
locations and tissue types in vivo, and it is not known whether
adaptive changes are responsible for direct virus-mediated out-
comes of infection, such as the invasion of the central nervous
system (CNS) and the subsequent development of giant cell
encephalitis (GCE). It is also unknown whether the ability of
HIV-1 to productively infect nonlymphoid tissues, such as the
brain, is dependent on the same adaptive changes that under-
line the CCR5-using, macrophage-tropic phenotype character-
ized in in vitro studies.
In this study we have used a combination of immunocyto-
chemical detection of p24 antigen (75), PCR for quantitation
of proviral DNA sequences (69), and genetic characterization
to examine the cell types and virological characteristics of HIV
infecting samples of lung and colon collected at autopsy from
a large number of HIV-seropositive individuals. We examined
the genetic relationships between HIV variants infecting dif-
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ferent cell types in these tissues and those recovered from
lymph nodes, where lymphocytes are the predominant cell type
infected, and also those present in the brains of individuals
with GCE, where the principal target cells are cells of the
monocyte/macrophage lineage (infiltrating macrophages and
microglia). Our findings provide evidence for the existence of
genetically distinct populations of HIV targeting cells of the
monocyte/macrophage lineage with shared distributions in the
CNS and tissue macrophages in the lung and gastrointestinal
(GI) tract. Biological characterization of variants recovered
from lymphoid and nonlymphoid cells identified in this study
will allow the phenotypic differences underlying the in vivo
differences in cellular tropism to be identified.
MATERIALS AND METHODS
Study subjects. All of the tissue samples used in this study were held in the
Brain and Tissue Bank of Edinburgh (Western General Hospital, Edinburgh,
United Kingdom). Tissue samples, including brain, lung, colon, and lymph node,
were obtained from 18 autopsies (NA425, NA021, NA020, NA017, NA272,
NA371, NA025, NA446, NA199, NA284, NA038, NA116, NA369, NA270,
NA308, NA246, NA420, NA118) from the cohort of HIV-infected individuals in
Edinburgh. All study subjects died of complications associated with HIV infec-
tion, including opportunistic infections or neoplasms. Their ages ranged from 32
to 49, and they had histories of HIV-1 infections lasting 4 to 13 years before
death. Other clinical and background information for the study group is listed in
Table 1. Previously determined proviral loads, V3 sequences, and immunocyto-
chemical detection of p24 antigen from three study subjects, NA246, NA118, and
NA420 (corresponding to p4, p5, and p6 [ref. 24]), were incorporated into the
larger series analyzed in this study.
During the autopsies, which were carried out within 3 days of death (Table 1),
approximately 1- to 2-cm3 samples of the left frontal region of brain, colon, lung,
and lymph node from each individual were dissected and stored at 70°C for
PCR and sequence analysis. The remaining tissues were fixed in 10% formalin
for histopathological examination. The intervals between death and autopsy were
comparable for the GCE and GCE groups (Table 1), indicating that this
variable was not a compounding factor in the differences observed between the
two groups in proviral loads found in autopsy samples of brain and colon.
DNA extraction and provirus quantitation. DNA was extracted from frozen
brain, lymph node, colon, and lung tissues as previously described (69). Total
DNA concentration was estimated by spectrophotometry at 260 nm. Proviral
load was determined by previously described limiting-dilution nested PCR (69)
using the previously described p17gag primer set (85). Twenty-four replicates at
last positive dilution were used to indicate the minimum proviral load in the
sample, assuming a Poisson distribution for each sample by the formulaln (1
p)/d, where p is the proportion of positive samples and d is the dilution (69). Viral
load was expressed as copies per million cells, based on the DNA composition of
human diploid cells of 6.6 pg of DNA.
Immunohistochemical examination. Approximately 2 weeks after formalin
fixation, autopsy tissues were processed through a routine 41-h program in the
Vacuum Infiltration Processor (Tissue Tek), followed by paraffin wax embedding
using a Tissue Tek embedding console. Five-micrometer sections of formalin-
fixed paraffin-embedded tissues from all of the study subjects were examined by
immunohistological staining with anti-HIV-1 p24 antibody (DuPont) and double
labeling with several cell markers, PGM1 (DAKO) for microglial/macrophage
cells, CD3 and CD8 (DAKO) for T cells, GFAP (DAKO) for astrocytes, and
CD21 (DAKO) for follicular dendritic cells, using the tyramide signal amplifi-
cation technique, as previously described (75).
Nucleotide sequencing and analysis. Nucleotide sequences from p17gag and
V3 region were amplified using previously described primers (68, 85). For the
majority of study subjects, single molecules of HIV-1 provirus were isolated by
limiting dilution and sequenced directly using the Thermal-cycle Sequenase kit
(Amersham). For seven of the study subjects (NA425, NA021, NA020, NA017,
NA272, NA371, and NA025), 1-g aliquots of extracted DNA were amplified
and cloned into pGEM, using T overhangs (pGEM-T easy vector system; Pro-
mega). Miniprepped DNA from clones were sequenced using the Sequenase
version 2.0 kit (United States Biologicals) following the manufacturers’ instruc-
tions. To avoid template resampling that may occur when the cloning method is
used to obtain sequences from samples with low frequencies of amplifiable
sequences, its application was restricted to samples with proviral loads greater
than 60 copies per 106 cells. Dideoxynucleotide sequencing of cloned DNA
sequences was carried out using USB sequenase 2.0 kit (Amersham Life Science)
with 35S-dATP, the thermosequenase-radiolabeled terminator cycle sequencing
kit, according to the manufacturer’s instructions.
TABLE 1. Proviral loads in lymphoid and nonlymphoid autopsy samples from study subjects
Subject HIV riskfactora
No. of lymphocytes
(counts/l) at time
of death
GCE
diagnosisb
Duration of infection Interval between
death and
autopsy (h)
V3
predictionc
CD4 CD8 HIV (yr) AIDS (mo)
NA371 M 0.5 56 N 4 30 11 Y
NA425 I 1 314 N 13 14 29 Y
NA116 I 4 60 N NKd 18 39 Y
NA20 M 8 388 N 13 48 21 Y
NA17 I 17 109 N 12 19 59 N
NA308 I 23 212 N 13 8 59 N
NA199 I 28 164 N 13 6 54 N
NA272 I 105 411 N 9 10 21 N
NA270 I 246 510 N 4 56 N
Median GCE 17 212 12 16 39
NA38 I 3 210 P 10 7 65 N
NA420 I 7 P NK NK 14 N
NA246 I 8 P 5 24 57 N
NA284 I 8 110 P NK 21 30 N
NA369 I 23 440 P 2 22 44 Y
NA118 I 56 P 9 NK 70 N
NA21 I 87 1,779 P 13 48 63 N
NA446 I 137 2,611 P 14 8 6 N
NA25 H 297 232 P 4 26 N
Median GCE 23 336 9 22 44
a M, Male homosexual; I, injecting drug user; H, heterosexual contact.
b Determined during autopsy examination of the brain. N, negative; P, positive.
c Presence of SI, CXCR4-dependent variants of HIV, predicted from V3 loop sequence (19, 32).
d NK, not known.
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Sequences were aligned using the Simmonic 2000 Sequence Editor package.
Phylogenetic trees were constructed by the neighbor-joining method using Jukes-
Cantor corrected sequence distances in the MEGA package (48). The nucleotide
sequences from p17gag and V3 regions from each of the study subjects were
compared with each other and with a range of standard HIV-1 variants. Each set
of sequences from the 12 study subjects compared was monophyletic in both
genomic regions and distinct from those of the published sequences of subtype
B: HIV-1SF2 (K02007), HIV-1RF (M17451), HIV-1OYI (M26727), HIV-1LAI
(K02013), HIV-1JRFL (M74978), HIV-1YU2 (M93258), HIV-1CAMI (D10112),
HIV-1NY5CG (M38431), HIV-1HAN (U43131), HIV-1WMJ22 (M12507), and
HIV-1SFAAA (M65024). This comparison provided no evidence for coinfection
with epidemiologically unrelated HIV strains, nor for intersample or exogenous
laboratory contamination.
Analysis of phylogenetic groupings. The degree of genetic segregation be-
tween variants recovered from different samples was scored using a novel
method for scoring phylogenetic trees. For each sequence comparison, a phy-
logeny was calculated with the programs DNADIST and NEIGHBOR in the
PHYLIP package (28) using an epidemiologically unlinked sequence (HIV-1SF2)
as an outgroup. Starting from the root of the tree, the composition of sequences
in each successive bifurcating node was calculated. An association value, d, for
the tree was calculated by summation of values individually calculated from each
node, according to the formula d  (1  f)/2n1, where n is the number of
sequences below the node and f is the frequency of most common sample type.
Values of d expected from the null hypothesis (i.e., for samples showing no
phylogenetic grouping) were calculated by random reassignment of the se-
quences to different samples. Finally, the influence of tree robustness on the
association value was indicated by bootstrap resampling using the program
SEQBOOT in the PHYLIP package. The association index (AI) represents the
mean ratio of 100 bootstrap replicates of the association value calculated from
the test sequences to those of 10 sample-reassigned controls.
Confidence intervals for AI values were difficult to calculate from first princi-
ples, as the variance depended on the number of sequences compared, the
degree of sequence divergence, and the phylogeny of the sequences. For the
purpose of this study, in which each comparison of tissue samples contained
similar numbers of sequence with similar divergence, we estimated confidence
intervals empirically for AI values using (sample-reassigned) control values from
independent lymph node and brain comparisons from 10 of the study subjects.
The distribution of AI values corresponded closely to a normal distribution
around 1, and confidence intervals for 2 standard deviations ranged from 0.74 to
1.36.
Nucleotide sequence accession numbers. The nucleotide sequences obtained in
the present study have been submitted to GenBank and have been assigned acces-
sion no. AF353734 through AF35394 and AF409200 through AF409685.
RESULTS
Detection of HIV-1 proviral sequences in nonlymphoid tis-
sue. DNA was extracted from the left frontal region of the
cerebral cortex in the brain, from lung, and from full-thickness
autopsy samples of colon from 18 HIV-infected individuals.
Proviral loads were measured by limiting-dilution PCR using
highly conserved primers from the p17gag region (Table 1).
High frequencies of infected cells in the lymph node samples
were detected in most individuals (range, 15 to 110,000 provi-
ral copies/106 cells).
Proviral loads in nonlymphoid tissue were more variable. In
brain, high proviral loads were observed only in study subjects
with a postmortem diagnosis of GCE (median proviral load,
540/106 cells compared with 6/106 cells in those without en-
FIG. 1. Comparison of proviral loads (copies per 106 cells) in samples from brain, colon, lung, and lymph node, and CD4 lymphocyte counts
between study subjects with and without GCE. Median proviral loads or CD4 counts are indicated by horizontal bars. Differences in distributions
of values between GCE and non-GCE groups were estimated using Mann-Whitney U test; P values are indicated above each graph.
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cephalitis; P  0.0003) (Fig. 1). Detection of proviral se-
quences in the colon samples was also more frequent in those
with GCE (Table 1), and there was a marked difference in
median proviral load between the GCE and nonGCE groups
(1,010/106 cells compared with 10/106 cells; P 0.006) (Fig. 1).
In contrast, there was no significant difference between the
GCE and non-GCE groups in the degree of infection of either
lung (median values, 600 [non-GCE] and 881 [GCE]; P 0.43)
or lymph node samples (median values 6,000 [non-GCE] and
4,100 [GCE], P  0.51) (Fig. 1). On individual comparison,
proviral loads from only brain and colon correlated with each
other (R  0.629 by Spearman’s rank correlation test; P 
0.01); all other pairwise comparisons of tissues produced low R
values (0.27553, 0.074, 0.20, 0.23, 0.35; P  0.1).
The detection of higher proviral loads in brain and colon
tissues of individuals with GCE could not be attributed to a
greater degree of disease progression. CD4 lymphocyte counts
of the two categories were similar at time of death (median
values of 17 [non-GCE] and 23 [GCE]; Fig. 1). As described
above, there was also no evidence for higher proviral loads in
lymph node autopsy specimens from the GCE group.
Localization and cytopathology of HIV-1 in vivo. Evidence
of productive infection by HIV-1 in each tissue was demon-
strated by immunocytochemical staining for p24 antigen using
the tyramide signal amplification method (Table 2). HIV-ex-
pressing cells were identified by double labeling or immuno-
staining sequential serial sections with anti-p24 antibody and
monoclonal antibodies (MAbs) to the cell surface markers
CD3 and CD8 (T lymphocytes), PG-M1 (macrophages and
brain microglia cells), L26 (B cells), and CD21 (follicular den-
dritic cells). Any p24-positive cells that were not recognized by
the cell markers listed above were stained using other cell
markers, such as glial fibrillary protein GFAP (for astrocytes),
depending on the observed morphology.
The majority of p24 in lymph node tissue was detected in
germinal centers of lymphoid follicles, colocalizing with CD21
(Fig. 2A and B). In only a few instances were p24-positive cells
detected in the paracortical area, indicating infrequent produc-
tive infection of T lymphocytes. The detection of HIV-1 p24
immunopositivity in the brain was strongly correlated with the
stage of disease. p24 detection was restricted to study subjects
diagnosed with GCE (Table 2). p24 detection was strongly
associated with proviral load measured by limiting-dilution
PCR (Table 1; P  0.0003). The main cell types infected with
HIV-1 in the brain were those of the monocyte/macrophage
lineage; p24 was detected primarily in multinucleated giant
cells (MGCs), perivascular mononuclear macrophages, and
microglial cells, all of which could be double stained with
PGM-1 (anti-CD68 MAb). The p24 staining in these cells was
granular and cytoplasmic and was present not only in cell
bodies but also in the processes of microglial cells (Fig. 2C and
D).
HIV-1 p24 antigen was detected in lung samples of 6 of the
18 study subjects examined. p24 detection was more frequent
in samples with high proviral loads (Table 1; P  0.005; Spear-
man’s rank correlation test). p24 detection in lung was gener-
ally restricted to germinal centers in peribronchial lymphoid
aggregates, and most of the p24-positive cells were morpho-
logically mononucleated (Fig. 2E). However, a large number of
infected MGCs which double stained with anti-p24 MAb and
the PGM-1 marker, were observed in subject NA246 (Fig. 2F).
p24 immunopositivity was detected in colon samples from
only two study subjects, in differing cell types. In the sample
from NA25, p24 was detected in lymphoid infiltrate in the
colon wall (Table 2). In contrast, p24 antigen expression was
detected in both the lymphoid infiltrates (Fig. 2G) and CD68-
positive cells with a tissue macrophage morphology in the
colon sample from NA284 (Fig. 2H). In this sample, infected
cells frequently formed pronounced multinucleated syncytia,
reminiscent of the appearance of infected macrophages in the
lung and microglia in the brain (Fig. 2D and F).
Nucleotide sequence analysis. The association between
GCE and high proviral loads in nonlymphoid tissue and the
histological evidence for infection of cells of the monocyte/
macrophage lineage in lung and colon in NA284 and NA246
suggested that HIV populations in nonlymphoid tissue may be
related to those infecting the brain.
To investigate genetic relationships between variants in dif-
ferent tissues, we sequenced the V3 hypervariable and flanking
regions from proviral sequences recovered from lymph node
tissue of each study subject and, where appropriate, from
brain, lung, and colon tissues. The proviral loads determined
by limiting dilution were essential in interpreting the sequenc-
ing results obtained, in view of the possibility that residual
blood contamination (particularly in highly vascular tissue such
as the lung) may contribute partly or entirely to the sequences
amplified by PCR.
Problems associated with analysis of sequences to define
distributions of sequences from different samples are the arbi-
trariness of the phylogenetic groups assigned and the absence
of any defensible statistical test to detect differences in the
TABLE 2. Detection of p24 antigen in lymphoid and nonlymphoid
autopsy samples from study subjects
Subject No. of CD4(counts/l)
GCE
diagnosisa LN
b
Nonlymphoid samplesc
LF CO LU
NA371 0.5 N  –d – –
NA425 1 N  – – 
NA116 4 N  – – –
NA20 8 N – – – –
NA17 17 N – – – –
NA308 23 N  – – –
NA199 28 N  – – 
NA272 105 N  – – –
NA270 246 N  – – –
NA38 3 P  QQQ – –
NA420 7 P  Q – –
NA246 8 P  Q – QQQ
NA284 8 P  QQQ , QQ –
NA369 23 P  QQ – –
NA118 56 P  QQ – 
NA21 87 P  QQQ – 
NA446 137 P  QQ – –
NA25 297 P  Q  
a LN, lymph node; N, negative; P, positive.
b Detection of p24 antigen in autopsy samples by immunocytochemistry; pos-
itive samples were graded on a scale from  (sparse) to  (frequent), based
on numbers of infected cells.
c p24 antigen expression detected in cells of monocyte/macrophage lineages is
indicated on a scale of Q (sparse), to QQQ (frequent). LF, left frontal region of
the brain; CO, colon; LU, lung.
d –, not detected.
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composition of the clades. We have developed a method to
analyze the large amount of sequence information generated
in the genetic comparison of V3 sequences from different tis-
sues from the 18 study subjects. The method is based on the
detection of deviation from randomness in the position of
sequences from different tissues in phylogenetic trees. A num-
ber of methods can be used to score the grouping of sequences
in trees; in this study, we calculated a numerical index (group-
ing value) that is derived from the composition of descendants
from each bifurcating node in a standard neighbor-joining tree.
Trees showing a high degree of compartmentalization of se-
quences would contain relatively few nodes with descendants
from different samples (in this case, from lymph node, brain,
lung, or colon), and would be assigned a lower grouping score
than for one where each descendant node contained mixed
variants. The grouping value for a sequence dataset without
compartmentalization (the null hypothesis) is also influenced
by the number of sequences analyzed and the shape of phylo-
genetic tree. Therefore, compartmentalization has to be dem-
onstrated by comparison of the grouping value with that cal-
culated for a control dataset that retains the same phylogeny.
The most convenient way to achieve this computationally is to
randomly reassign the sequence labels, while retaining the
relative numbers of sequences from each compartment and the
tree structure. In the analysis presented here, a mean value
from 10 label reassignments was used for each control value.
Finally, the grouping value is also dependent on the robust-
ness of the tree analyzed. For this reason, grouping values were
calculated on 100 sets of bootstrap-resampled replicates of the
sequences, each with 10 sample label reassignments. Sequence
datasets with grouping values consistently lower than label-
reassigned controls therefore showed evidence for tissue-spe-
cific compartmentalization. Although the method can detect
groupings in datasets containing sequences from any number
of tissue compartments, grouping values are most relevant for
comparing pairs of samples (such as brain and lymph node). To
allow for different values from control sequences, results from
the association test are expressed as an association index, AI,
which is the ratio of the association value of sequences over
that of controls). Examples of phylogenetic trees and their
derived AI values for sequence comparisons between lymphoid
and nonlymphoid tissues are shown in Fig. 3.
Comparisons of HIV proviral sequences from different tis-
sues. Approximately 10 V3 and flanking region sequences were
obtained from the frontal region tissues of the nine study
subjects with GCE. These sequences were compared with
those amplified from lymph node (Table 3). With one excep-
tion (NA38; AI value, 0.52), brain V3 sequences were phylo-
genetically distinct from the lymphoid HIV population (AIs
from 0.03 to 0.0002).
For other tissues, phylogenetic relationships with lymphoid
populations were more variable. Most samples from lung au-
topsy tissue contained proviral populations that were inter-
spersed with lymph node sequences (Table 3), with only two
study subjects showing clearly distinct lung populations. All
lung-derived sequences from NA25 segregated separately from
lymph node sequences (Table 3), while lung sequences from
NA246 comprised two viral populations, one interspersed with
lymph node sequences and another grouping separately (see
below). There was no association between proviral loads in
lung and their degree of sequence relatedness to lymphoid-cell
populations (Tables 1 and 3).
Sequences from colon also showed variable relationships
with the lymphoid populations; approximately half of the colon
samples (from NA420, NA246, NA284, NA21, and NA25, all
with evidence of GCE) contained sequences grouping sepa-
rately from those in lymph node samples (Table 3). There was
a tendency for colon samples with high viral loads to show
greater genetic segregation, although this difference did not
reach statistical significance.
To provide independent evidence for genetic segregation of
proviral populations in lymphoid and nonlymphoid cells, sam-
ples from seven study subjects were sequenced in the p17gag
region and association indices were calculated (Fig. 4). There
was a close correlation between sequence relationships from
the two genomic regions (R  0.71; P  0.0002 by Spearman’s
rank correlation test), demonstrating substantial concordance
about which populations were genetically distinct and which
were interspersed. An outlier from this association was NA425,
for which samples from colon were genetically distinct from
lymph node samples in the p17gag region (AI, 0.0022) but
interspersed in V3 (AI, 0.41).
Genetic relationships between nonlymphoid populations.
The combination of the previously described findings suggests
that virus populations in the brain (in which the principal
target cells are microglia; Fig. 2C and D) may be genetically
linked to those in nonlymphoid populations, particularly in
samples with infection of tissue macrophages (NA284 and
NA246). In all study subjects with GCE, except for NA38,
variants infecting the brain were distinct from those in lym-
phoid tissue, potentially allowing the identification of mac-
rophage-associated populations elsewhere. Analysis was con-
centrated on the four individuals with evidence for infection of
the colon and/or lung with variants of HIV genetically distinct
from those in lymph node (NA420, NA246, NA284, and NA25;
Fig. 5). All four individuals showed evidence for GCE, and
comparison was therefore also made with variants amplified
from the left frontal region.
V3 sequences from lymph node, brain, lung, and colon of
NA246 grouped into two main phylogenetic groups. One con-
tained exclusively variants from nonlymphoid tissue, with se-
quences from brain, colon, and lung interspersed with each
FIG. 2. Identification of HIV-expressing cells from different tissues in vivo. (A and B) Serial sections of lymph node from NA25 immunostained
with diaminobenzidine, using monoclonal antibodies to CD21 (A) and p24 antigen (B), localizing HIV to follicle center. (C) Low-power
magnification of section of brain tissue from NA21 immunostained for p24 antigen, showing cluster of p24 antigen-expressing cells. (D) Higher
magnification of same section as for panel C, costained for p24 antigen with DAB and for CD68 with new fuchsin red. (E) Lung tissue from NA21
showing p24 antigen expression in lymphoid follicle. (F) Same section as for panel E, identifying p24 expression (DAB) on MGCs expressing CD68
(new fuchsin red). (G) Colon tissue from NA284 showing p24 antigen expression in lymphoid follicle. (H) Same section as for panel G, identifying
p24 expression (DAB) on MGCs expressing CD68 (new fuchsin red).
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other. The other lineage contained predominantly lymph
node-derived variant, with some from lung. The genetic divi-
sion between lymphoid- and nonlymphoid-derived variants was
also observed for NA25; this subject’s sequences from brain,
colon, and lung were mixed in the two clades which contained
exclusively nonlymphoid tissue variants. Sequence relation-
ships for the remaining two individuals were more complex.
Sequences from brain, colon, and lymph node from NA246
FIG. 3. Examples of phylogenetic comparisons between sequences from lymph node with brain (left), lung (center), and colon (right) from
samples showing high (upper panel) and low (lower panel) AI values. Trees were constructed by the neighbor-joining method using the MEGA
package; frequency of bootstrap replicates supporting individual clades is indicated on branches (only values 70% are shown). All trees were
plotted to the scale indicated by the bar at the bottom of the figure.
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each grouped separately from each other, with a colon-specific
population distinct from both lymphoid variants and those
from brain. Finally, most colon-derived variants from NA284
formed a separate clade which also contained lymph node
sequences. These sequences shared a basic amino acid at po-
sition 320 in the V3 loop, associated with a CXCR4-dependent
phenotype (Fig. 6). The remaining colon sequences grouped in
a separate clade which contained the sequences from brain;
these sequences had a predicted CCR5-dependent phenotype.
Sequences in the p17gag regions were obtained from NA284
and NA25 (Fig. 5). Sequence relationships in the p17gag region
were generally congruent with those in V3, with genetic com-
partmentalization of lymph node sequences similar to those
derived from nonlymphoid tissue. A noticeable difference was
the grouping of colon-derived sequences from NA284. While
the majority of V3 sequences grouped in a separate clade with
lymph node sequences, there was no evidence for shared
grouping of colon and lymph node sequences in the p17gag
region. Instead, all sequences from the colon were interspersed
with those from the brain.
Summarizing the results of this comparison, most variants
from colon and lung showed common genetic lineages with
proviral sequences recovered from brain, while sequences re-
sembling those from lymphoid tissue were generally in the
minority in both V3 and p17gag regions. However, sequences
from nonlymphoid tissue were not always monophyletic, and in
the case of NA246 there was a tripartite division between
brain-, colon-, and lymph node-derived variants. Taken to-
gether, however, the comparisons reveal a closer genetic rela-
tionship between sequences within nonlymphoid tissue than
with those derived from infected lymphocytes.
Comparison of V3 hypervariable region amino acid se-
quences. To investigate whether variants from nonlymphoid
tissue shared sequence motifs in the V3 region which distin-
guished them from lymphoid populations, a consensus amino
acid sequence for variants from each tissue from the four study
subjects was calculated (Fig. 6A). Each consensus sequence in
this comparison showed acidic or neutral residues at positions
306 and 320 in the V3 loop. By 2 analysis, there were no
residues differentiating lymphoid and nonlymphoid sample
types or individual nonlymphoid tissues that were shared be-
tween different study subjects in the V3 loop or flanking re-
gions.
To investigate whether the occurrence of GCE was associ-
ated with particular sequences in the V3 region, consensus
sequences from lymph node were calculated from each study
subject. This analysis was complicated by the occurrence of
various proportions of V3 sequences associated with CXCR4
usage in samples from six of the study subjects (Table 1). As
these are genetically distinct from viruses with predicted CCR5
usage, separate V3 consensus sequences were calculated for
each (Fig. 6B and C). For either predicted phenotype, there
was no evidence for any systematic difference between sequences
from individuals with and without GCE in the distribution of
amino acids at a particular site or combination of sites.
DISCUSSION
Limiting-dilution PCR was used to quantify proviral se-
quences in a range of lymphoid and nonlymphoid autopsy
tissues from HIV-infected individuals. Consistent with previ-
ous studies (1, 7–9, 25, 57), there was a strong association
between the development of HIV-related GCE and proviral
load measured in a representative sample of the brain. For the
subjects analyzed in this study, ranges of proviral loads be-
tween GCE and GCE groups were almost nonoverlapping
(Fig. 1). Identification of infected cells in the brain and in other
tissues was carried out by immunocytochemical staining for
p24 antigen expression and was therefore restricted to cells
containing actively replicating virus. p24 antigen staining was
FIG. 4. Comparison of association indices calculated from p17gag
sequences (x axis) and V3 sequences (y axis). Symbols: E, comparison
between lymph node- and nonlymphoid tissue-derived sequences; F,
comparison between nonlymphoid sequences.
TABLE 3. Association indices for pairwise comparison of proviral
sequences from different tissuesa
Subject
Association index for sequences from:
LN and LF LN and CO LN and LU CO and LF
NA371 –b – 0.25 –
NA425 – 0.41 – –
NA116 – 0.26c NDd –
NA20 – – 0.56 –
NA199 – 0.44 – –
NA38 0.52 0.56 – 0.50
NA420 0.019 0.033 – 0.0087
NA246 0.029 0.030 0.18 0.26
NA284 0.0020 0.095 – 0.067
NA369 0.0086 0.71 – 0.036
NA118 0.059 – 0.40 –
NA21 0.00024 0.28 0.85 0.0052
NA446 0.044 0.52 – 0.0066
NA25 0.0027 0.12 0.012 0.089
a LN, lymph node; LF, left frontal region of the brain; CO, colon; LU, lung.
b Sequences unavailable for comparison.
c Association index values indicating separate virus populations are set in bold.
d ND, not done.
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FIG. 5. Phylogenetic comparison of lymph node, lung, colon, and brain sequences from the four study subjects with evidence for separate
proviral populations in colon and/or lung samples. p17gag region sequences from NA284 and NA25 are placed in reversed orientation on the right.
Trees were constructed by the neighbor-joining method using the MEGA package; the frequencies of bootstrap replicates supporting individual
clades are indicated on branches (only values70% are shown). All trees were plotted to the scale indicated by the bar at the bottom of the figure.
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localized to CD68 cells of the macrophage/monocyte lineage
in the CNS. Morphologically, CD68 cells corresponded both
to perivascular microglia and macrophages and to microglia in
the brain parenchyma, although more precise identification
awaits the development of markers to distinguish cells of this
lineage. None of the findings presented in this paper rule out
the possibility for additional restricted or latent infection by
HIV of other cell types in the CNS. For example, there may be
nonproductive infection of astrocytes (reviewed in reference
11), associated with the expression of nonstructural gene prod-
ucts such as Nef (21, 44, 65), although whether they contribute
significantly to the proviral population detected by PCR awaits
more precise quantitative studies based on methods such as in
situ PCR (4, 76) which do not rely on gene expression for
detection of infected cells.
CNS viral populations in brain autopsy samples from the
study subjects were relatively uniform in the V3 region of env
and genetically distinct from variants infecting lymph node
tissue in eight of the nine study subjects (Fig. 3 and 6), con-
sistent with a large number of previous studies (6, 22, 24, 27,
33, 34, 36, 43, 45, 52, 53, 56, 58, 62, 63, 74, 81). While this
overwhelming body of evidence of compartmentalization sug-
gests the existence of adaptive differences involved in infection
of the CNS, it has been alternatively hypothesized that differ-
ences in the rates of virus turnover in different cell types may
lead to the population differences observed between brain and
lymph node, given the rapid temporal change in HIV popula-
tions over time in peripheral blood mononuclear cells and
other lymphoid cell types (45). However, the strict association
between proviral load and the detection of replicating virus in
the CNS by immunocytochemistry and the likelihood of con-
tinuous trafficking of HIV-infected cells through the blood
brain barrier and intermingling of HIV variants at this inter-
face (59, 83) are inconsistent with the concept that CNS-de-
rived sequences represent an inactive or slower-replicating ar-
chival HIV population. Further indirect evidence for a
functional difference with lymphoid- and CNS-derived virus
variants is provided by the comparison of sequence relation-
ships in the env gene with regions elsewhere in the genome not
involved in cellular tropism, such as gag (41, 56). To summarize
a large amount of comparative sequence information, only
sequences derived from the V1/V2 and V3 regions demon-
strated consistent tissue specificity; brain-derived sequences in
the p17gag region showed much greater sequence diversity and
in some individuals or from certain brain regions may be ge-
netically indistinct from those recovered from lymphoid tissue.
Greater diversity and weaker partitioning are also evident from
the comparison of V3 and p17gag sequences in the present
FIG. 6. (A) Comparison of consensus V3 region amino acid sequences from lymphoid and nonlymphoid samples from the four study subjects
with distinct colon and/or lung proviral populations. (B and C) Comparison of lymph node-derived sequences from study subjects with and without
GCE; separate consensus sequences are shown for V3 sequences with predicted CCR5-dependent (B) and CXCR4-dependent (C) phenotypes.
Symbols: x, no overall consensus; ., sequence identity with HIV-1SF2.
VOL. 75, 2001 MACROPHAGE/MONOCYTE-SPECIFIC POPULATIONS OF HIV-1 11695
study (Fig. 5). Given the propensity of HIV to frequently
recombine in vivo, the restriction of tissue specificity to V1/V2
and V3 provides evidence for phenotypic selection in this re-
gion not exerted elsewhere in the genome.
Direct evidence for differences in cellular tropism between
HIV variants recovered from CNS and lymphoid tissues has
been obtained by comparison of the biological properties of
virus isolated from the CNS and virus isolates passaged
through microglia or through the characterization of infectious
clones or pseudotypes constructed from env gene sequences
amplified from brain and lymphoid tissue (13, 23, 35, 55, 67, 72,
84). All brain-derived or microglia-passaged variants analyzed
to date require CD4 for virus attachment and use predomi-
nantly or exclusively the chemokine receptor CCR5 for entry
(2, 13, 18, 23, 37, 38, 51, 67, 72, 84). This clearly is not the
defining feature of CNS-derived viruses, as the majority of
HIV variants derived from lymphoid cell types also use CCR5.
Indeed, while there is a consensus that CCR5 is the principal
coreceptor by which HIV enters cells of the macrophage/
monocyte lineage, additional phenotypic differences are likely
to underlie the specific macrophage tropism demonstrated by
certain HIV-1 isolates.
Evidence supporting the hypothesis for additional factor(s)
required for productive infection of macrophages includes the
observations that many CCR5-using isolates of HIV fail to
infect macrophages in vitro (14, 18, 23, 42, 71). Macrophages
can be infected in vitro through the CXCR4 receptor by dual-
tropic isolates of HIV (17, 38), while still retaining an apparent
preferential tropism for macrophages (18). In vitro passaging
of a blood-derived CCR5-using isolate of HIV-1 in microglia
led to the emergence of a variant with an enhanced ability to
replicate in macrophages, a change in phenotype dependent on
amino acid changes in the V1/V2 hypervariable region (55, 67).
These changes had no apparent effect on its usage of CCR5 or
other coreceptors but enhanced its ability to use low cell sur-
face concentration of CD4 for attachment. This may have
direct adaptive advantages for infection of cells of the macro-
phage/monocyte lineage, where levels of CD4 expression are
lower than on the surfaces of CD4 lymphocytes (55, 60, 67).
Together, these observations indicate the complexity of the
HIV-macrophage interaction and support the original hypoth-
esis for multiple entry or postentry restrictions to their pro-
ductive infection (31), additional to requirements for CD4 and
CCR5 cell surface expression. Adaptive changes required for
replication in macrophages, and not coreceptor usage, may
therefore underlie the consistent sequence differences between
brain and lymph node populations in this study and previous
genetic analyses of autopsy-derived tissues. This is particularly
relevant for published comparisons of brain- and lymph node-
derived variants of HIV-1 in which there are no differences in
net V3 charge that might suggest use of different coreceptors.
A close association between macrophage tropism and the
ability of isolates to infect microglia has been long recognized
(35, 46, 66, 77, 82), although whether infection of microglia or
neurovirulence requires additional adaptive changes remains
unclear. In the simian immunodeficiency virus macaque model
of AIDS, it has been shown that the gp120 gene determines
macrophage tropism, while sequences in gp41 and/or nef are
required for neurotropism (54). The lack of an animal model
has precluded comparable investigations of neurovirulence of
HIV-1, although there is evidence for similar or identical rep-
lication kinetics of various CCR5-using isolates in macro-
phages and microglia in vitro (35, 38, 77), indicating similarity
in the phenotypic determinants underlying tropism for the two
cell types. The development of GCE may therefore reflect the
evolution of HIV variants, capable of infecting not only cells of
the CNS but also macrophage populations in other nonlym-
phoid tissues. The relationship between the development of
GCE and infection of macrophage populations elsewhere in
the body was the focus of our quantitative and genetic com-
parison of HIV proviral sequences in different autopsy tissues.
Relationship between infections of the CNS and of other
nonlymphoid tissues. The most striking link between the oc-
currence of GCE and infection of other nonlymphoid tissues
was the observation of significantly higher proviral loads in
colon samples of the study subjects with GCE (Fig. 1). This
phenomenon was not the result of differences in disease pro-
gression, treatment history, or extent of destruction of lym-
phoid tissue between the GCE and GCE groups on autopsy
examination (data not shown). Similarly, there was no signifi-
cant difference in CD4 count before death, nor were there
differences in proviral loads in lymph node samples between
the two groups (Fig. 2). These observations led us to the
hypothesis that the development of GCE reflects a broader
tendency of some virus infections to spread beyond lympho-
cytes to other cell types in nonlymphoid tissues.
The finding of increased proviral loads in colon samples in
the GCE group was associated with the frequent detection of
V3 sequences closely related to those found in the CNS and
distinct from those in lymphoid tissues (NA246, NA284, NA25;
Fig. 5). The finding of virus populations distinct from lymphoid
tissue in some colon autopsy specimens is consistent with pre-
vious observations for partial genetic partitioning of HIV be-
tween GI-and blood-derived samples. For example, different
frequencies of antiviral resistant variants in gut mucosal biopsy
samples with circulating virus in plasma were obtained from a
minority of individuals (61). Similarly, V3 sequence differences
were frequently found between variants of HIV recovered
from feces and those found in peripheral blood (79, 80).
In one case, it was possible to detect p24 antigen-positive
CD68 MGCs in the mucosal layer of the colon, representing
productive infection of tissue macrophages. The associated
syncytial cytopathology was strikingly reminiscent of giant cells
associated with GCE in the brain. V3 sequences from the colon
of this individual comprised two populations; one group con-
tained positively charged residues at positions 322 and 324 and
grouped with lymph node-derived variants (Fig. 5, 6). The
others were closely similar to those recovered from the CNS
(Fig. 5). As this sample showed both macrophage infection and
lymphoid cell infiltration (Table 2), it is possible that the
former cell types harbored the HIV variants similar to those in
the CNS. We are currently using microdissection to allow the
separate genetic analysis of macrophage- and lymphoid-asso-
ciated infected cells in this autopsy sample to confirm this
hypothesis. Despite this example, detection of productively
infected macrophages in the GI tract by p24 antigen immuno-
cytochemistry was infrequent in this series and has been pre-
viously described in only one case report (49). It is possible that
restricted replication of HIV in macrophages prevented the
detection of infected macrophages in other colon samples
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where there was evidence for the presence of CNS-related
variants. Restricted or latent infection may result from the
reduced expression of CCR5 found in gut-derived macro-
phages compared with those derived from blood monocytes or
in microglia (50, 73). More extensive analysis of sections by
immunocytochemistry or the application of in situ PCR to
identify latently infected cells may help resolve this issue.
In contrast to infection of the colon, that of the lung was
almost invariably the result of lymphoid infiltration. There was
no association between proviral load in lung and the develop-
ment of GCE (Fig. 1), and V3 and p17gag sequences from
variants infecting lung tissue were generally interspersed with
those from lymph node (Table 3). The evidence for lack of
genetic partitioning between lymph node- and lung-derived
HIV variants is consistent with previously observed similarities
between lymph node and lung env sequences (71) and suggests
extensive trafficking and infection of similar cell types between
the two tissue types. Supporting this, p24 antigen detection
was, with one exception, confined to lymphoid follicle centers
(Table 2).
However, the sample from NA246 showed a high frequency
of p24 antigen-positive CD68 giant cells, representing the
productive infection of alveolar macrophages. This histological
picture was remarkably similar to the observed infection of
infected macrophages in the colon samples from NA284 (see
above). Genetic analysis of V3 sequences from the lung sample
of NA246 revealed two distinct virus populations; the majority
form (6 of 10) grouped with brain-derived variants, while two
were interspersed with lymph node-derived sequences. As with
the colon samples, it is possible that these different populations
of lung-derived variants have specific associations with the
observed giant cells in the alveoli and the lymphoid cells infil-
trating the lung.
Mechanism of infection of nonlymphoid tissue. The com-
bined genetic and immunohistochemical findings in this study
provide evidence of at least two distinct mechanisms for infec-
tion of nonlymphoid tissue. Infiltration of lymphoid cells, per-
haps in response to inflammatory processes associated with
opportunistic infection, was most evident in the lung and was
observed to a lesser extent in the colon, but it was not a feature
of the lymphoid infiltrates in the CNS. Infection of nonlym-
phoid tissue was alternatively or additionally manifested by the
appearance of productively infected CD68 cells of the mac-
rophage/monocyte lineage, in which giant cell formation was a
marked histological feature. This pattern of infection typified
that of the CNS but was also found in colon and lung samples
of two study subjects, both of which harbored virus populations
closely related to those found in the brain.
This study forms the basis for future functional analysis of
macrophage-associated populations in vivo. In particular, it
will be important to determine whether the colon and lung-
associated variants from NA284 and NA21 show evidence for
greater phenotypic similarities to CNS-derived variants than
the lymphoid-related variants recovered from corresponding
samples of other study subjects. Secondly, it will be relevant to
establish whether the particular ability of certain variants of
HIV to infect cells of the macrophage/monocyte lineage re-
flects larger-scale epidemiological differences between HIV
variants infecting injecting drug users (IDUs) in Edinburgh
and other risk groups. HIV infection in the majority of Edin-
burgh IDUs, including those described in the present study,
originated from a common source introduced into a specific
suburb of Edinburgh around 1982-1983 (12, 40, 64). Despite
careful analysis of compounding factors, such as treatment
compliance and risk-taking behavior, it has remained difficult
to account for the much higher incidence of GCE in this group
than in other risk groups in Edinburgh or in IDU cohorts in
other cities (8, 9). One possibility is that the virus introduced
into this group has a greater propensity for infection of mac-
rophages than other subtype B variants of HIV. Phenotypic
analysis of the variants genetically characterized in the present
study, with particular attention to the existence of specific
adaptive changes, such as efficient use of lower cell surface
CD4 concentration for attachment previously associated with
macrophage tropism (55, 60, 67), will provide an important test
of this theory and an insight into the disease manifestations
outside the CNS in this group.
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